Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NUS

NUS - Nu Skin Enterprises Inc Stock Price, Fair Value and News

$10.09-0.61 (-5.70%)
Market Closed

68/100

NUS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

68/100

NUS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$15.01

Target 3M

$11.93

Target 6M

$12.88

NUS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NUS Price Action

Last 7 days

-9.1%

Last 30 days

3.7%

Last 90 days

-5.0%

Trailing 12 Months

45.8%

NUS RSI Chart

NUS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NUS Valuation

Market Cap

491.9M

Price/Earnings (Trailing)

4.49

Price/Sales (Trailing)

0.32

EV/EBITDA

2.55

Price/Free Cashflow

9.22

NUS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$15.01

Target 3M

$11.93

Target 6M

$12.88

NUS Fundamentals

NUS Revenue

Revenue (TTM)

1.6B

Rev. Growth (Yr)

-15.33%

Rev. Growth (Qtr)

-5.68%

NUS Earnings

Earnings (TTM)

109.6M

Earnings Growth (Yr)

105.72%

Earnings Growth (Qtr)

-19.13%

NUS Profitability

EBT Margin

7.70%

Return on Equity

13.7%

Return on Assets

7.69%

Free Cashflow Yield

10.85%

NUS Investor Care

Buy Backs (1Y)

1.93%

Diluted EPS (TTM)

2.19

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.7B1.6B1.6B0
20241.9B1.8B1.8B1.7B
20232.1B2.0B2.0B2.0B
20222.6B2.5B2.4B2.2B
20212.7B2.8B2.8B2.7B
20202.3B2.3B2.4B2.6B
20192.7B2.6B2.5B2.4B
20182.4B2.6B2.7B2.7B
20172.2B2.2B2.1B2.3B
20162.2B2.2B2.2B2.2B
20152.4B2.4B2.3B2.2B
20143.3B3.3B3.0B2.6B
20132.2B2.3B2.7B3.2B
20121.8B2.0B2.0B2.1B
20111.6B1.6B1.6B1.7B
20100001.5B
Get all data in R, Python etc through our Historical Stock Data APIs

About Nu Skin Enterprises Inc

NUS
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
 CEO
 WEBSITEnuskin.com
 SECTORConsumer Defensive
 INDUSTRYHousehold & Personal Products
 EMPLOYEES3800

Nu Skin Enterprises Inc Frequently Asked Questions

NUS is the stock ticker symbol of Nu Skin Enterprises Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Nu Skin Enterprises Inc is 491.89 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NUS's fair value in chart for subscribers.

The fair value guage provides a quick view whether NUS is over valued or under valued. Whether Nu Skin Enterprises Inc is cheap or expensive depends on the assumptions which impact Nu Skin Enterprises Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUS.

As of Wed Jan 28 2026, NUS's PE ratio (Price to Earnings) is 4.49 and Price to Sales (PS) ratio is 0.32. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUS PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Nu Skin Enterprises Inc has provided -0.108 (multiply by 100 for percentage) rate of return.